Biology of chronic lymphocytic leukemia in different microenvironments: clinical and therapeutic implications

Yair Herishanu1, Ben-Zion Katz, Andrew Lipsky

  • 1Hematology Institute, Tel-Aviv Sourasky Medical Center, Tel-Aviv 64239, Israel.

Insights

Chronic lymphocytic leukemia (CLL) involves B cell accumulation regulated by the microenvironment. Understanding these interactions is key to developing new CLL therapies targeting its biology.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Chronic lymphocytic leukemia (CLL) is a mature monoclonal B cell malignancy.
  • CLL cell fate is influenced by interactions within the tissue microenvironment.
  • Recent advances highlight the reciprocal relationship between CLL cells and their surroundings.

Purpose of the Study:

  • To review the role of the microenvironment in CLL biology.
  • To discuss how microenvironmental interactions inform novel therapeutic strategies for CLL.

Main Methods:

  • Literature review of recent advances in CLL microenvironment research.
  • Analysis of reciprocal interactions between CLL cells and microenvironmental components.

Main Results:

  • The microenvironment significantly regulates CLL cell trafficking, survival, and proliferation.
  • Antigenic stimulation, accessory cells, cytokines, and extracellular matrix are key mediators.
  • Understanding these interactions is crucial for targeted therapy development.

Conclusions:

  • The CLL microenvironment is a critical factor in disease pathogenesis.
  • Targeting microenvironmental interactions offers promising avenues for novel CLL therapeutics.